The evolution of poxvirus vaccines

L Sánchez-Sampedro, B Perdiguero, E Mejías-Pérez… - Viruses, 2015 - mdpi.com
After Edward Jenner established human vaccination over 200 years ago, attenuated
poxviruses became key players to contain the deadliest virus of its own family: Variola virus …

Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity

J Lin, S Sun, K Zhao, F Gao, R Wang, Q Li… - Nature …, 2023 - nature.com
The advantage of oncolytic viruses (OV) in cancer therapy is their dual effect of directly
killing tumours while prompting anti-tumour immune response. Oncolytic parapoxvirus ovis …

Oncolytic viruses and immunity

S Chaurasiya, NG Chen, Y Fong - Current opinion in immunology, 2018 - Elsevier
Highlights•Oncolytic viruses (OVs) elicit innate and adaptive immune responses against
tumors.•Although the immune system can react against OVs, a functional immune system is …

Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells

LH Tai, CT De Souza, S Bélanger, L Ly, AA Alkayyal… - Cancer research, 2013 - AACR
Natural killer (NK) cell clearance of tumor cell emboli following surgery is thought to be vital
in preventing postoperative metastases. Using a mouse model of surgical stress, we …

The application of autologous cancer immunotherapies in the age of memory-NK cells

GD Lizana-Vasquez, M Torres-Lugo, RB Dixon… - Frontiers in …, 2023 - frontiersin.org
Cellular immunotherapy has revolutionized the oncology field, yielding improved results
against hematological and solid malignancies. NK cells have become an attractive …

VEGF-mediated induction of PRD1-BF1/Blimp1 expression sensitizes tumor vasculature to oncolytic virus infection

R Arulanandam, C Batenchuk, FA Angarita… - Cancer Cell, 2015 - cell.com
Oncolytic viruses designed to attack malignant cells can in addition infect and destroy tumor
vascular endothelial cells. We show here that this expanded tropism of oncolytic vaccinia …

[HTML][HTML] Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage …

JP Van Vloten, K Matuszewska… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Novel therapies are needed to improve outcomes for women diagnosed with
ovarian cancer. Oncolytic viruses are multifunctional immunotherapeutic biologics that …

Oncolytic viruses as anticancer vaccines

N Woller, E Gürlevik, CI Ureche, A Schumacher… - Frontiers in …, 2014 - frontiersin.org
Oncolytic virotherapy has shown impressive results in preclinical studies and first promising
therapeutic outcomes in clinical trials as well. Since viruses are known for a long time as …

Maraba MG1 virus enhances natural killer cell function via conventional dendritic cells to reduce postoperative metastatic disease

J Zhang, LH Tai, CS Ilkow, AA Alkayyal, AA Ananth… - Molecular therapy, 2014 - cell.com
This study characterizes the ability of novel oncolytic rhabdoviruses (Maraba MG1) to boost
natural killer (NK) cell activity. Our results demonstrate that MG1 activates NK cells via direct …

Orf virus: A promising new therapeutic agent

R Wang, Y Wang, F Liu, S Luo - Reviews in Medical Virology, 2019 - Wiley Online Library
The orf virus (ORFV) is a zoonotic, epitheliotropic, DNA parapoxvirus that infects principally
sheep and goats. Exposure of animals to the virus or immunization by an ORFV preparation …